The polycystic ovarian syndrome (or PCOS) is one of the most complex disorders that could affect the female reproductive system. Those who suffer from it exhibit a series of unpleasant symptoms and usually battle with infertility, but there isn’t a permanent cure for it. While researchers have always been wondering where it came from, they might have finally found an answer that could lead to a better treatment.
What is PCOS?
Women who suffer from PCOS have their ovaries covered in small cysts filled with fluids. Those who suffer from the condition experience unpleasant symptoms like severe pelvic pain, weight gain, excessive hair growth or thinning of hair, hormonal issues, or even infertility. The percentage of women who have the syndrome can vary from 8 to 20 percent, and it can cause a series of other issues.
One can detect the condition by spotting high levels of one specific male hormone, androgen, in the patients. If left untreated, the disease might be a starting point for diabetes, but there’s actually no cure for it. PCOS is extremely complex and, so far, researchers couldn’t explain any cause for it.
PCOS might be linked to high levels of a specific hormone
However, a team of researchers from France developed a study that might be a breakthrough for the treatment of PCOS. They discovered that pregnant women with the condition have high levels of a specific hormone in their blood. This hormone, called anti-Müllerian, is produced by the ovarian follicles, and is a good fertility sign.
This is the first time when researchers realized there was a connection between the anti-Müllerian hormone and PCOS. They tested their hypothesis in mice, and discovered that higher levels of the hormone led to the newborns developing the syndrome. It seems this specific hormonal imbalance increased the levels of male hormones in female babies.
Researchers also found a possible cure for PCOS. They injected the mice with a common fertility drug called cetrorelix. While it prevents the egg from releasing too soon, it reduced the symptoms of the disorder in mice. However, researchers still need to perform some studies before finding the optimal treatment for humans.
The study was published in the journal Nature.
Image source: Pixabay